I've written this kind of article before, addressing whether it's smart to buy into the dividend-paying stocks in the S&P 500 ...

Explore the Hipgnosis founder's new venture, focused on music management and co-ownership for artists and managers.

Merck Mercuriadis, the architect behind Hipgnosis’s transformation of music rights into a mainstream asset class, is making a ...

SCHD's quality-focused approach sets it apart from other high-yield ETFs, as it focuses on financial strength and strong ...

Merck Mercuriadis aims to buy back the music rights he sold to the private equity firm while building a new investment ...

Hipgnosis, which Mercuriadis launched in 2018 to buy song rights and was sold last year, is back with bigger ambitions.

With a $10 billion deal for the Los Angeles Lakers, Guggenheim CEO Mark Walter is adding another trophy asset to a portfolio ...

From health to hair care, the experts broke down exactly how artificial intelligence is shaping Black futures and why we can’t afford to sit this one out.

Second, SoFi could grow its revenue even without expanding its membership base, by cross-selling additional products to its existing users. The company recorded 15.9 million products in Q1. That means ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...

Sean “Diddy” Combs would have a hard time launching a comeback despite his acquittal on the most severe charges because of ...

Merck Foundation Chairman, CEO with First Ladies of Africa & Asia at 7th Edition of Merck Foundation First Ladies Initiative ...